Amaryllis Tsiknia, United States of America

UC San Diego Neurosciences

Presenter of 2 Presentations

SEX DIFFERENCES IN THE RELATIONSHIP BETWEEN CARDIOVASCULAR DISEASE RISK AND CORTICAL TAU

Session Type
SYMPOSIUM
Date
14.03.2021, Sunday
Session Time
08:00 - 10:00
Room
On Demand Symposia B
Lecture Time
08:00 - 08:15
Session Icon
On-Demand

Abstract

Aims

Cardiovascular health plays a pivotal role in the development and progression of Alzheimer’s Disease (AD). Traditional cardiovascular risk factors impact cardiovascular health to different extents in men and women. Given recent evidence that women on the AD trajectory bear a larger burden of tau pathology than men, we investigated whether cardiovascular disease risk differentially impacts cortical tau in men and women.

Methods

We calculated the Framingham Heart Study Cardiovascular Disease (FHS-CVD) risk algorithm at baseline in 172 participants from the AD Neuroimaging Initiative study. Our sample was composed of 113 cognitively normal participants and 59 participants with mild cognitive impairment. We quantified cortical tau using Flortaucipir PET acquired on average 5.51 ± 1.3 years after baseline FHS-CVD assessment. We used linear regression analyses to test for interaction effects between sex and FHS-CVD on subsequent cortical tau, correcting for age, APOE e4 genotype and time between initial FHS-CVD assessment and tau PET.

Results

We found that women had significantly higher levels of tau then men in areas including BRAAK 3&4, (p = 0.001; BRAAK 5&6,(p < 0.0001) regions. We found significant interaction effects of sex and FHS-CVD on subsequent BRAAK 3&4 (p=0.017) and BRAAK 5&6 tau (p=0.019). When stratifying by sex, higher baseline FHS-CVD measurement was associated with higher cortical tau in women (BRAAK 3&4, p=0.029; BRAAK 5&6, p=0.026) but not men.

Conclusions

These results suggest that despite being at lower cardiovascular disease risk, women are more heavily impacted by the effects of cardiovascular risk on tau pathology than men.

Hide